App may cut hospital phone calls for cancer patients
NCT ID NCT06371911
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study tested whether adding a telemonitoring app (Cureety) to standard care could reduce the number of phone calls hospital staff need to make to patients receiving injectable cancer treatments. The app collects blood test results and symptom reports to identify which patients need a call. The study involved 192 adults starting injectable anticancer therapy in France. The goal was to ease staff workload while maintaining safe care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS INITIATING INJECTABLE ANTICANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre François Baclesse
Caen, 14000, France
-
Centre de Radiothérapie et Oncologie Médicale d'Osny
Osny, France
-
Centre hospitalier de Bligny
Bligny, France
Conditions
Explore the condition pages connected to this study.